针灸治疗原发性纤维肌痛:随机对照试验研究方案
本研究为随机、盲法、安慰对照试验,在两家医院开展,计划纳入68例符合美国风湿病学会诊断标准的原发性纤维肌痛患者,按1:1随机分配至针灸组或假针灸组。干预8周,随访16周,每4周评估一次,主要结局为VAS疼痛强度和FIQR,次要结局包括疲劳、生活质量、抑郁、睡眠、压力、压痛点数、满意度和不良事件。
要点
- 针刺治疗纤维肌痛疗效尚不明确,本试验采用假针刺对照评估疗效与安全性。
- 主要结局为VAS和FIQR评估的疼痛强度,每4周评估一次至6个月。
- 计划纳入68例患者,随机1:1分配,干预8周,随访16周。
核心结论
- 该试验旨在评估针灸治疗纤维肌痛的疗效和安全性,结果可能为针灸治疗提供临床证据。
研究设计与样本
- 随机、盲法、安慰对照试验,两个队列分别在广安门医院和深圳市中医院开展。
- 计划纳入68例符合美国风湿病学会诊断标准的原发性纤维肌痛患者,按1:1随机分配至针灸组或假针灸组。
- 干预8周,每4周随访评估一次,共随访16周。
关键数值与推荐
- 主要结局采用VAS和修订版纤维肌痛影响问卷(FIQR)评估疼痛强度。
- 次要结局包括多维疲劳评估量表(MAF)、SF-36、贝克抑郁量表(BDI)、匹兹堡睡眠质量指数(PSQI)、中文感知压力量表(pss-14)、18个压痛点数量变化、治疗满意度和不良事件。
- 结局指标每4周评估一次,持续6个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acupuncture is well recognized for its unique therapeutic effect for many diseases as a nonpharmacological therapy in traditional Chinese medicine (TCM). However, whether acupuncture can effectively treat fibromyalgia is currently unclear. Therefore, we aim to design a study protocol of a randomized controlled clinical trial and assess the effectiveness of acupuncture for patients with fibromyalgia, which may lead to alleviation of clinical symptoms and improvement of patients' quality of life. METHODS: The study is designed as a randomized, blinded, placebo-controlled trial of two cohorts conducted at Guang'anmen Hospital of China Academy of Chinese Medical Sciences and Shenzhen Traditional Chinese Medicine Hospital, respectively. A total of 68 patients with primary fibromyalgia, diagnosed with the American College of Rheumatology criteria, are randomly allocated with a 1:1 ratio to acupuncture or sham acupuncture groups. All subjects will receive acupuncture intervention for 8 weeks with follow-up assessments every 4 weeks for 16 weeks. The primary outcome will be evaluated using the visual analogue scale (VAS) and revised fibromyalgia impact questionnaire (FIQR) for pain intensity. The secondary outcome measures will include: Multidimensional Assessment of Fatigue scale (MAF), Short Form-36 (SF-36), Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), Chinese perceived stress scales (pss-14), changes in the number of 18 tender points, patient satisfaction for the treatment and adverse events. The mentioned outcome measurements will be assessed every 4 weeks for 6 months. DISCUSSION: This clinical trial will use advanced research methods to evaluate the efficacy and safety of acupuncture on fibromyalgia. The results of this trial may provide clinical evidence on the beneficial effects of acupuncture in treating fibromyalgia. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR1800016826: AMCTR-IOR-18000184. Registered 27 June 2018, http://www.acmctr.org/listbycreater.aspx.
引用
- Han M, Cui J, Xiao Y, et al. Acupuncture for primary fibromyalgia: Study protocol of a randomized controlled trial. Trials. 2020. PMID: 32552731. doi:10.1186/s13063-020-04317-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。